Search
Displaying 721–730 of 1010 results
-
First Patient Receives AON Therapy for LCA10 in ProQR’s Phase 2/3 Clinical Trial
Research NewsThe treatment, formerly known as QR-110, is designed for people with the retinal disease Leber congenital amaurosis 10
-
Recent News Items Featuring the Foundation Fighting Blindness
-
Full Transcript - 2019 Investing in Cures Summit - March 2, 2019
Full Session Transcripts of the 2019 Investing in Cures Summit.
-
Investing in Cures Summit - March 2, 2019
Audio from the 2019 Investing in Cures Summit, held on March 2, 2019
-
Subsription Management Page
